Expression of estrogen receptor-α, glucocorticoid receptor, β-catenin and glycogen synthase kinase-3β in the uterus of mice following long-term treatment with estrogen and glucocorticoid hormones

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 107, Issue 1, 2003, Pages 62-67

  Gunin, Andrei G ^a   Emelianov, Vladimir U ^a   Tolmachev, Alexei S ^a  

^a CHUVASH STATE UNIVERSITY   (Russian Federation)

Author keywords

Estrogen receptor; Estrogens; Glucocorticoid receptor; Glucocorticoids; Glycogen synthase kinase 3 ; Uterus; Catenin

Indexed keywords

BETA CATENIN; DEXAMETHASONE; DRINKING WATER; ESTROGEN; ESTROGEN RECEPTOR ALPHA; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; HYPERPLASIA; MOUSE; NONHUMAN; OBSERVATION; PARAMETER; PRIORITY JOURNAL; UTERUS;

EID: 0037467398     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(02)00375-5     Document Type: Article

References (26)

1. Emons G., Fleckenstein G., Hinney B., Huschmand A., Heyl W. Hormonal interactions in endometrial cancer. Endocr. Relat. Cancer. 7:2000;227-242.
2. Gunin A.G., Mashin I.N., Zakharov D.A. Proliferation, mitosis orientation and morphogenetic changes in the uterus of mice following chronic treatment with both estrogen and glucocorticoid hormones. J. Endocrinol. 169:2001;23-31.
3. Couse J.F., Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us. Endocrinol. Rev. 20:1999;358-417.
4. Gunin A.G. Estrogen changes mitosis orientation in the uterine epithelia. Eur. J. Obstet. Gynecol. Reprod. Biol. 97:2001;82-86.
5. Atkinson S., Adams N.R. Adrenal glands alter the concentration of oestradiol-17 beta and its receptor in the uterus of ovariectomized ewes. J. Endocrinol. 118:1988;375-380.
6. Rabin D.S., Johnson E.O., Brandon D.D., Liapi C., Chrousos G.P. Glucocorticoids inhibit estradiol-mediated uterine growth: possible role of the uterine estradiol receptor. Biol. Reprod. 42:1990;74-80.
7. Jan Y.N., Jan L.Y. Polarity in cell division: what frames thy fearful asymmetry. Cell. 100:2000;599-602.
8. 2+ pathways. Oncogene. 18:1999;7860-7872.
9. Abu-Jawdeh G., Comella N., Tomita Y., Brown L.F., Tognazzi K., Sokol S.Y.et al. Differential expression of frpHE: a novel human stromal protein of the secreted frizzled gene family. Lab. Invest. 79:1999;439-447.
10. Bui T.D., Zhang L., Rees M.C., Bicknell R., Harris A.L. Expression and hormone regulation of Wnt2, 3, 4, 5a, 7a, 7b and 10b in normal human endometrium and endometrial carcinoma. Br. J. Cancer. 75:1997;1131-1136.
11. Das S.K., Tan J., Raja S., Halder J., Paria B.C., Dey S.K. Estrogen targets genes involved in protein processing, calcium homeostasis, and Wnt signaling in the mouse uterus independent of estrogen receptor-alpha and -beta. J. Biol. Chem. 275:2000;28834-28842.
12. Fujimoto J., Ichigo S., Hori M., Tamaya T. Alteration of E-cadherin, alpha- and beta-catenin mRNA expression in human uterine endometrium during the menstrual cycle. Gynecol. Endocrinol. 10:1996;187-191.
13. Sassoon D. Wnt genes and endocrine disruption of the female reproductive tract: a genetic approach. Mol. Cell Endocrinol. 158:1999;1-5.
14. Kitajewski J., Sassoon D. The emergence of molecular gynecology: homeobox and Wnt genes in the female reproductive tract. Bioessays. 22:2000;902-910.
15. Gunin A.G., Sharov A.A., Nikolaev D.V. Two month glucocorticoid treatment increases estradiol-induced stromal and myometrial cell proliferation in the uterus of ovariectomized rats. Eur. J. Obstet. Gynecol. Reprod. Biol. 88:2000;171-179.
16. Gunin A.G., Emelianov V., Tolmachev A.S.A.T. Effect of prolactin and dopaminergic drugs on uterine response to chronic estrogen exposure. J. Endocrinol. 172:2002;61-69.
17. Takahashi M., Tomizawa K., Ishiguro K. Distribution of tau protein kinase I/glycogen synthase kinase-3beta, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain. Brain Res. 857:2000;193-206.
18. Gunin A.G., Emelianov V., Tolmachev A.S.A.T. Effect of prolactin and dopaminergic drugs on uterine response to chronic estrogen exposure. J. Endocrinol. 172:2002;61-69.
19. Ray D. Molecular mechanisms of glucocorticoid resistance. J. Endocrinol. 149:1996;1-5.
20. Bamberger C.M., Schulte H.M., Chrousos G.P. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocrinol. Rev. 17:1996;245-261.
21. Deligdisch L. Hormonal pathology of the endometrium. Mod. Pathol. 13:2000;285-294.
22. Ali S.H., O'Donnell A.L., Balu D., Pohl M.B., Seyler M.J., Mohamed S.et al. Estrogen receptor-alpha in the inhibition of cancer growth and angiogenesis. Cancer Res. 60:2000;7094-7098.
23. Schlesinger A., Shelton C.A., Maloof J.N., Meneghini M., Bowerman B. Wnt pathway components orient a mitotic spindle in the early Caenorhabditis elegans embryo without requiring gene transcription in the responding cell. Genes. Dev. 13:1999;2028-2038.
24. Fujimoto J., Ichigo S., Hori M., Tamaya T. Expressions of E-cadherin and alpha- and beta-catenin mRNAs in uterine endometrial cancers. Eur. J. Gynaecol. Oncol. 19:1998;78-81.
25. Nei H., Saito T., Yamasaki H., Mizumoto H., Ito E., Kudo R. Nuclear localization of beta-catenin in normal and carcinogenic endometrium. Mol. Carcinog. 25:1999;207-218.
26. Miyamoto S., Baba H., Kuroda S., Kaibuchi K., Fukuda T., Maehara Y.et al. Changes in E-cadherin associated with cytoplasmic molecules in well and poorly differentiated endometrial cancer. Br. J. Cancer. 83:2000;1168-1175.